These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1385050)

  • 1. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.
    Hansen SW
    Dan Med Bull; 1992 Oct; 39(5):391-9. PubMed ID: 1385050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
    Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.
    Glendenning JL; Barbachano Y; Norman AR; Dearnaley DP; Horwich A; Huddart RA
    Cancer; 2010 May; 116(10):2322-31. PubMed ID: 20225230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
    Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
    Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.
    Hansen SW; Helweg-Larsen S; Trojaborg W
    J Clin Oncol; 1989 Oct; 7(10):1457-61. PubMed ID: 2476531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
    Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
    Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
    Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
    Sweeney C
    Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PVB therapy for advanced testicular cancer].
    Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Miyakoda K
    Hinyokika Kiyo; 1989 Nov; 35(11):1871-5. PubMed ID: 2482672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
    Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
    J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.
    Petersen PM; Hansen SW
    Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.